Washington, United States — Pfizer and BioNTech said Wednesday that a completed study of their experimental COVID-19 vaccine showed it was 95 percent effective.
They said the two-dose vaccine had no serious safety concerns and that the companies will apply for emergency use authorization from US regulators “within days.”
The announcement came as coronavirus cases are surging in the US and other parts of the world, and boosted hopes for an end to the pandemic that has upended life around the globe.
“The study results mark an important step in this historic eight-month journey to bring forward a vaccine capable of helping to end this devastating pandemic,” said Pfizer CEO Albert…
Keep on reading: Pfizer/BioNTech say final results show vaccine 95% effective